Elon's Biggest Secret Could Save Your Retirement

From a near-fatal car crash to surviving deadly malaria, Musk's fearless drive built Tesla, SpaceX, and Starlink. Now, he's warning America--and smart investors are listening. Discover the Trump IRS Loophole to protect your IRA & 401(k).

Eventful Monday For AstraZeneca - What's Going On?

Vandana Singh
March 17, 2025

On Monday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and safety of eneboparatide in adults with chronic hypoparathyroidism.

The study showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary endpoint with statistical significance at 24 weeks in adults with chronic hypoparathyroidism (HypoPT) compared to placebo.

The primary endpoint is a composite of normalization of albumin-adjusted serum calcium levels and independence from active vitamin D and oral calcium therapy.

Also Read: AstraZeneca’s Imfinzi-Based Regimen Shows Improved Event-Free Survival In Early-Stage Gastric Cancer Patients

HypoPT is a rare endocrine disease caused by a deficiency of PTH and is characterized by impaired regulation of calcium and phosphate levels in the blood. Eneboparatide was well tolerated.

After the 24-week randomized treatment period, all patients receive eneboparatide in the ongoing long-term extension until 52 weeks. Full efficacy and safety data will be analyzed at 52 weeks.

Concurrently, AstraZeneca and Alteogen entered into an exclusive license agreement for ALT-B4, a hyaluronidase utilizing Hybrozyme platform technology.

Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialize subcutaneous formulations of several oncology assets.

Alteogen will be responsible for the clinical and commercial supply of ALT-B4 to AstraZeneca.

AstraZeneca will pay Alteogen an upfront payment and additional payments upon achieving specific development, regulatory, and sales-related milestones. Additionally, Alteogen will receive royalties on the sales of the commercialized products.

On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults with limited-stage small cell lung cancer whose disease has not progressed following platinum-based chemoradiation therapy.

The approval is based on results from the ADRIATIC Phase 3 trial.

The trial showed that Imfinzi reduced the risk of death by 27% compared to placebo.

The estimated median overall survival was 55.9 months for Imfinzi versus 33.4 months for placebo. An estimated 57% of patients treated with Imfinzi were alive at three years compared to 48% for placebo.

Imfinzi also reduced the risk of disease progression or death by 24% versus placebo.

The median progression-free survival (PFS) was 16.6 months for Imfinzi versus 9.2 months for placebo. An estimated 46% of patients treated with Imfinzi had not experienced disease progression at two years compared to 34% for placebo.

Earlier on Monday, AstraZeneca agreed to acquire cell therapy focused-EsoBiotec SA for up to $1 billion.

Price Action: At the last check on Monday, AZN stock was down 1.04% to $76.78 during the premarket session.

Read Next:

  • Hain Celestial Valuation Is Low Versus Historical Levels, But Analyst Remains Neutral – Here’s Why

Image by Robert Way via Shutterstock

Continue Reading...

Popular

Vancouver International Auto Show removes Tesla, citing safety concerns at event

VANCOUVER, British Columbia (AP) — Tesla has been removed from participating in this week’s Vancouver International Auto Show over safety concerns, the event’s executive director said Tuesday.

Just Released: Huge New A.I. Trade - Ad

While everyone's distracted by Nvidia, PLTR & Bitcoin, billionaires have been quietly loading up on this stock. And 99% of Americans have no clue. It could help make a fortune for fast-moving investors, who make their move before May 13th.

North Carolina Republicans seek to force top Democrats to fall in line with Trump agenda

RALEIGH, N.C. (AP) — North Carolina Republicans who are resolved to promote President Donald Trump’s agenda now seek to compel the recently elected Democratic governor to aid the president's immigration crackdown and stop the new Democratic attorney general from fighting Trump in court.

Mortgage lender Rocket Cos. to acquire real estate brokerage Redfin in deal valued at $1.75 billion

Mortgage lender Rocket Cos. has agreed to acquire online real estate brokerage Redfin in an all-stock deal valued at $1.75 billion.

The 2025 'Trump Shock' [401K Owners Stunned] - Ad

Trump's Gold Reset? A massive dollar overhaul could be coming! Insiders say Trump may return America to the gold standard--sending gold prices soaring. He's been stockpiling gold for decades... should you? Discover how to legally move funds from your IRA & 401(k) into gold tax-free!

How to roll over an old 401(k)

Old are a little like the old clothes in the back of your closet. You know you should do something about them, but there they sit, mostly out of sight and mind.

Wall Street Pioneer's AI Warning: "I thought we had more time..." - Ad

A radical new AI development is about to blindside millions of Americans. This early pioneer just issued an urgent warning explaining everything.

Asian shares slip as investors brace for further uncertainty over tariffs, await US jobs report

BANGKOK (AP) — Asian shares were mostly lower on Friday, with Tokyo’s benchmark down more than $2 after a on Wall Street.

Albania shuts down TikTok for a year amid concerns over violence among children

TIRANA, Albania (AP) — The Albanian Cabinet decided on Thursday to shut down for 12 months, blaming the popular video-sharing platform for inciting violence and bullying, especially among children.

What should you be doing to "AI-Proof" your retirement? - Ad

AI is creeping into every aspect of our daily lives... According to billion-dollar fund manager Louis Navellier, it's never been more important to AI-proof your wealth. He lays out three simple steps to take ASAP in his new video.

Bristol Myers Acquired MyoKardia Drops Fulcrum Agreement, Ending Cardiomyopathy Research Deal

MyoKardia, a Bristol Myers unit, is terminating its agreement with Fulcrum Therapeutics, ending a cardiomyopathy research deal set to expire in June 2025.

AI pioneers who channeled 'hedonistic' machines win computer science's top prize

Teaching machines in the way that animal trainers mold the behavior of dogs or horses has been an important method for developing artificial intelligence and one that was recognized Wednesday with the top computer science award.

Warning: What They Haven't Told You (Yet) About the 2025 Selloffs - Ad

In light of massive recent selloffs... Stansberry Research has issued a new warning for the public. Their latest research shows the real truth about the 2025 tariff selloffs is much bigger -- and much worse -- than the public realizes. They say unless you take the right steps now... You could soon see your wealth cut in half.

Panama president calls Trump's talk of 'reclaiming' the Panama Canal a lie

PANAMA CITY (AP) — Panama President José Raúl Mulino on Wednesday accused U.S. President Donald Trump of lying when he said in his address to Congress that his administration was “reclaiming” the Panama Canal.

Three New Patents Reveal Elon and Trump's Secret "Project America" - Ad

Three patents could help President Trump and Elon Musk completely revolutionize a $23 Trillion market. This revolution is about so much more than just self-driving cars. Instead, what Elon's pivoting Tesla towards... Is a market that's 1,000X BIGGER. But a project THIS big can't stay under the radar for long...

Massive Losses For Crypto Traders As MELANIA Memecoin Plummets

A crypto trader has reportedly suffered a staggering loss of $15.68 million after trading the official memecoin of First Lady Melania Trump.

Iranian government official who was key to 2015 nuclear deal resigns under hard-liner pressure

TEHRAN, Iran (AP) — A former Iranian foreign minister who was key to the country's 2015 nuclear deal with world powers reportedly tendered his resignation on Monday from the government of reformist , caving in to pressure from hard-liners.

The DOGE Shock: Nine Stocks to Buy - Ad

They say that DOGE's real agenda could shock the entire stock market in the coming days - sending a handful of widely unknown stocks soaring. And they've compiled the definitive investment playbook for anyone who wants the opportunity to capitalize.

Elon Musk's DOGE Team Has Door Slammed On It At Africa Aid Agency Amid Raging Turf War

DOGE team members were denied entry to the U.S. African Development Foundation amid tensions over Trump's executive order targeting independent agencies.

Cathie Wood's Ark Invest Continues To Load Up On Tempus AI, Dumps Bitcoin-Focused Block In Tech Meltdown Aftermath

On Tuesday, Cathie Wood‘s Ark Invest executed notable trades, including significant activity involving Tempus AI Inc. (NASDAQ:TEM), Block Inc. (NYSE:XYZ), and DraftKings Inc.<

The Last Time Gold Flashed This Warning Sign, the Market Dropped 80% - Ad

Both President Trump and Elon Musk are warning about something that could send the market down 50%, real estate down 40% and savings accounts down 30%.

Trump signs executive order to establish government bitcoin reserve

President Donald Trump signed an executive order Thursday establishing a , a key marker in the cryptocurrency's journey towards possible mainstream acceptance.

Small Plane Crashes In Pennsylvania Retirement Facility Parking Lot After Pilot Reports 'Open Door'

A Beechcraft Bonanza carrying five people crashed Sunday afternoon near a retirement village south of Lancaster Airport in Pennsylvania, according to Federal Aviation Administration officials. All passengers survived and were transported to hospitals for treatment.

Bill Gates' Next Big AI Bet: Stargate Could Be a Game-Changer - Ad

Jeff Brown, the tech expert who predicted Bitcoin, Nvidia, and Tesla, reveals Bill Gates' new AI project, Stargate. Could this be the next big AI breakthrough?

Arthur Hayes: 'Be Patient' - Bitcoin's 36% Correction Is Just Another Bull Market Move

BitMEX co-founder Arthur Hayes remains unfazed by Bitcoin's (CRYPTO: BTC) recent correction, viewing it as part of a natural cycle in a bull market. He believes macroeconomic forces will determine the next major move.  

Universities are facing big cuts to research funding. At Duke, it's a time for 'damage control'

DURHAM, N.C. (AP) — Facing the potential loss of hundreds of millions of dollars in federal funding, Duke University is preparing for the worst.

Warning: China Launches AI Attack on America - Ad

China just launched what can only be described as an AI attack on America. And according to Louis Navellier, the legendary investor who picked Nvidia before shares exploded as high as 3,423%... President Trump is already planning a counter attack. And it's creating an incredible opportunity for you in this small group of AI stocks.

Trump's tariff tactics carry higher economic risks than during his first term

WASHINGTON (AP) — When Donald Trump started the biggest trade war since the 1930s in his first term, his impulsive combination of threats and import taxes on U.S. trading partners created chaos, generated drama -- and drew criticism from mainstream economists who favor free trade.

Oregon police investigate nighttime gunshots that shattered windows at a Tesla dealership

PORTLAND, Ore. (AP) — Police in Oregon said Thursday they are working with the FBI to investigate gunshots fired at a Tesla dealership overnight in the latest instance of vandalism at one of the company's retail stores.

The Fort Knox Cover-up? What It Means for Gold - Ad

Trump and Musk are demanding answers: Is Fort Knox empty? If the gold is gone, supply collapses, and prices could skyrocket instantly. Right now, I've uncovered 5 major gold predictions that could make this Fort Knox moment even bigger than people realize. One of them is already unfolding--and the window to act is closing fast.

AT&T Confirms 2025 Targets, Cash Flow Strength And Debt Reduction Plan: Details

AT&T reaffirms 2025 financial targets, plans to execute long-term strategic plan. Expects strong first quarter of 2025, maintains dividend.

What's Going On With SoundHound AI Stock Friday?

SoundHound shares are moving higher on Friday after the company announced it will participate in the 2025 Nvidia GPU Technology Conference.

Washington Won't Save You--but This 4-Step Plan Might - Ad

America's economy is unraveling--soaring costs, skyrocketing debt, and Wall Street insiders dumping stocks. This isn't a recession--it's an economic breakdown. Stocks could crash 50%, real estate 40%, and inflation will eat your savings. But history shows: the biggest crashes create the biggest fortunes--if you act now!

Asian shares decline despite rebound on Wall St as investors await next steps in trade wars

BANGKOK (AP) — Asian shares were mostly lower on Thursday despite a rebound on Wall Street fueled by an on U.S. consumer prices.

The $20 Trillion Secret of Room 3330 - Ad

Developed by the U.S. military 79 years ago, this controversial technology is about to change American life forever: Elon Musk has already funneled $6 billion to resurrect this covert project -- and the companies involved are minting 10,000 millionaires every week [Goldman Sachs].

Who is Mark Carney, the next prime minister of Canada?

TORONTO (AP) — Former central banker Mark Carney will become Canada’s next prime minister after a Liberal Party leadership vote in a landslide.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service